Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03749499 · ClinicalTrials.gov registry record · NA
Targeting of UnControlled Hypertension in Emergency Department
A NA study of Hypertension and Cardiovascular Diseases, sponsored by University of Illinois at Chicago.
- Completed
- Registry status
- NA
- Development phase
- 574
- Enrollment target
- 1
- Study location
NCT03749499 is a NA study of Hypertension and Cardiovascular Diseases that has completed, run by University of Illinois at Chicago. The registered enrollment target is 574 participants, below the 3,506-participant average among 470 other Hypertension trials with a reported enrollment target (84% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03749499, a NA study of Hypertension and Cardiovascular Diseases, has completed, sponsored by University of Illinois at Chicago.
- COMPLETED
- Registry status
- NA
- Development phase
- 574 participants
- Enrollment target
- 1
- Study location
Study Summary
The proposed project underscores the following: 1) The prevalence of uncontrolled/undiagnosed hypertension (HTN) in underrepresented groups presenting to the ED is alarmingly high, and 2) ED engagement and early risk assessment/stratification is a cost-effective, feasible innovation to help close health disparity gaps in HTN. This proposal involves a two-arm randomized controlled trial of up to 770 patients from the Emergency Department at University of Illinois Hospital with elevated blood pressure (BP). The primary objective is to determine the effectiveness of an emergency department-initiated Educational and Empowerment (E2) intervention with a Post Acute Care Hypertension Consultation (PACHT-c) intervention (arm 2) on the primary outcome of mean systolic blood pressure (SBP) differences between the two trial arms at 6-months post intervention. Secondary objectives include evaluating the effectiveness of this ED education and empowerment intervention on mean SBP and diastolic blood pressure (DBP) differences at 3-months, and mean DBP differences at 6-months.
Conditions Studied
Interventions
- OTHER HTN Educational Video
- OTHER Visual Echocardiogram Image Clips
- OTHER Mobile Health and Remote BP monitoring
- OTHER Post-Acute Care HTN Transition consultation (PACHT-c)
Study Locations (1)
Illinois
- University of Illinois at Chicago - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 574 participants |
| Start Date | 2019-02-19 |
| Est. Completion | 2023-03-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03749499
The ClinicalTrials.gov registry entry for NCT03749499 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 574 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,506-participant average among 470 other Hypertension trials with a reported enrollment target (84% lower). The listed sponsor is University of Illinois at Chicago, which has 430 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Hypertension appearing as the primary indexed condition, and to 4 interventions - of which HTN Educational Video is the first listed.
NCT03749499 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.
Frequently Asked Questions
What is clinical trial NCT03749499 about?
NCT03749499 is a clinical study titled "Targeting of UnControlled Hypertension in Emergency Department". The proposed project underscores the following: 1) The prevalence of uncontrolled/undiagnosed hypertension (HTN) in underrepresented groups presenting to the ED is alarmingly high, and 2) ED engagement and early risk assessment/stratification is a cost-effective, feasible innovation to help close he...
What is the current status of trial NCT03749499?
This trial is currently completed. It is a NA study. The enrollment target is 574 participants. The study started on 2019-02-19. Estimated completion is 2023-03-31.
What conditions does trial NCT03749499 study?
This clinical trial studies the following conditions: Hypertension, Cardiovascular Diseases, Vascular Diseases.
What interventions are being tested in trial NCT03749499?
The interventions under investigation include: HTN Educational Video (OTHER), Visual Echocardiogram Image Clips (OTHER), Mobile Health and Remote BP monitoring (OTHER), Post-Acute Care HTN Transition consultation (PACHT-c) (OTHER).
Who is sponsoring clinical trial NCT03749499?
This trial is sponsored by University of Illinois at Chicago, which has 430 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03749499 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hypertension
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Ketone Ester And Salt (KEAS) in Older Adults
RECRUITING · NA
-
How a Mediterranean Diet With Potatoes Impacts Heart and Metabolic Health in Adults With Pre-Diabetes
RECRUITING · NA
-
Conical Forearm and Cylindrical Upper Arm Non-Invasive Blood Pressure (NIBP) Measurements in Pregnant Patients
RECRUITING · NA
-
Comparing Healthcare Visit Recording and Open Notes to Improve Chronic iLlness Care Experience in Older Adults
RECRUITING · NA
-
Early Time-Restricted Eating in Older Adults With Hypertension
RECRUITING · NA
-
Targeting Metabolic Syndrome From the Emergency Department Through Mixed-Methods: Pilot Trial
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.